Global Multiple Sclerosis Drugs Market By Type (Immunomodulators, Interferons, Immunosuppressants), Route Of Administration (Oral, Parenteral), Distribution Channel (Hospital Pharmacy, Online Pharmacy) By Region and Companies - Industry Segment Outlook, Market Assessment, Competition Scenario, Trends and Forecast 2023-2032
- Published date: Nov 2023
- Report ID: 51496
- Number of Pages: 215
- Format:
-
-
-
- Celgene Corporation
- AbbVie Inc. Company Profile
- Acorda Therapeutics Inc.
- Actelion Pharmaceuticals (Johnson & Johnson)
- Adamas Pharmaceuticals Inc
- Bayer AG Company Profile
- Biogen Inc.
- Cipla Inc.
- Eli Lilly and Company
- EMD Serono (Merck KGaA)
- Pfizer Inc Company Profile
- Sanofi Company Profile
- Teva Pharmaceuticals Industries Ltd.
- Novartis AG.
- Bristol-Myers Squibb Company
- Hoffmann-La Roche Ltd.
- Other Key Players
Our Clients
✖
Request a Sample Report
We'll get back to you as quickly as possible